Wirshing D A, Wirshing W C, Marder S R, Liberman R P, Mintz J
Department of Psychiatry, West Los Angeles VA Medical Center, CA 90073, USA.
Am J Psychiatry. 1998 Nov;155(11):1508-11. doi: 10.1176/ajp.155.11.1508.
The authors designed and evaluated a structured and rigorous informed consent procedure involving subjects with schizophrenia.
Informed consent forms were read and explained to 49 schizophrenic patients participating in ongoing clinical treatment research trials. The subjects answered a questionnaire relating to each research protocol. Protocol procedures were reiterated until the patients answered 100% of the questions correctly. Subjects were asked the same questions 7 days later to ascertain how much of the information they had retained.
The patients' median score on the first trial of the informed consent questionnaire was 80% correct. To achieve 100% correct responses, 53% of the patients required a second trial of the questionnaire, and 37% of them required three or more trials. Scores improved between the first trial and the trial on day 7. Ninety-six percent of the subjects felt adequately informed, 66% reported participating in the research protocol for personal reasons, and 34% reported participating at the suggestion of others.
These findings demonstrate that when adequate informed consent procedures are established, schizophrenic research subjects are able to understand and retain critical components of informed consent information.
作者设计并评估了一种针对精神分裂症患者的结构化且严谨的知情同意程序。
向49名参与正在进行的临床治疗研究试验的精神分裂症患者宣读并解释知情同意书。受试者回答了与每个研究方案相关的问卷。研究方案程序被反复重申,直到患者正确回答所有问题。7天后再次向受试者询问相同问题,以确定他们记住了多少信息。
在知情同意问卷的首次测试中,患者的中位数得分正确率为80%。为了达到100%的正确回答率,53%的患者需要进行第二次问卷测试,其中37%的患者需要进行三次或更多次测试。从首次测试到第7天的测试,得分有所提高。96%的受试者认为已充分了解相关信息,66%报告因个人原因参与研究方案,34%报告是应他人建议参与。
这些研究结果表明,当建立了充分的知情同意程序时,精神分裂症研究受试者能够理解并记住知情同意信息的关键部分。